Topics covered include are payers helping or hindering biosimilar market access as well as can MCDA ...
Read moreThe objective of this research was to determine the national price submission procedures across Euro...
Read moreA best practice guide for companies seeking parallel scientific HTA advice has been published by the...
Read moreWhether ICER will become an integral part of the US healthcare landscape in the future remains to be...
Read moreAn update on UK market access at EUCOPE meeting
Read moreThis study determines if EU pricing and reimbursement bodies have revised their pricing and reimburs...
Read moreA recent publication from the WHO identifies that EU pharmaceutical drug prices are too high and tha...
Read more